Fatemeh Tajik

578 total citations
33 papers, 307 citations indexed

About

Fatemeh Tajik is a scholar working on Oncology, Molecular Biology and General Health Professions. According to data from OpenAlex, Fatemeh Tajik has authored 33 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 7 papers in Molecular Biology and 5 papers in General Health Professions. Recurrent topics in Fatemeh Tajik's work include Cancer Cells and Metastasis (4 papers), Intraperitoneal and Appendiceal Malignancies (4 papers) and Ovarian cancer diagnosis and treatment (4 papers). Fatemeh Tajik is often cited by papers focused on Cancer Cells and Metastasis (4 papers), Intraperitoneal and Appendiceal Malignancies (4 papers) and Ovarian cancer diagnosis and treatment (4 papers). Fatemeh Tajik collaborates with scholars based in Iran, United States and United Kingdom. Fatemeh Tajik's co-authors include Saghar Khani, Fatemeh Pashazadeh Kan, Samira Raoofi, Ahmad Ghashghaee, Fatemeh Torabi, Sepide Rezaei, Hossein Hosseinifard, Sima Rafiei, Saba Ahmadi and Afsaneh Dehnad and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Fatemeh Tajik

31 papers receiving 299 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fatemeh Tajik Iran 9 106 57 55 44 36 33 307
Omar M. Omar United States 8 99 0.9× 37 0.6× 61 1.1× 36 0.8× 23 0.6× 20 262
Ze-Fang Ren China 9 159 1.5× 112 2.0× 60 1.1× 109 2.5× 53 1.5× 12 386
Takahiro Kubo Japan 14 192 1.8× 38 0.7× 98 1.8× 25 0.6× 43 1.2× 40 511
Ya-Ling Weng Taiwan 5 151 1.4× 28 0.5× 37 0.7× 33 0.8× 25 0.7× 5 325
Julie Brevard United States 11 96 0.9× 23 0.4× 111 2.0× 67 1.5× 29 0.8× 18 512
María Cristina Quijano Martínez Colombia 10 55 0.5× 53 0.9× 32 0.6× 35 0.8× 14 0.4× 57 415
Andrea P. Malizia Italy 12 59 0.6× 46 0.8× 124 2.3× 13 0.3× 20 0.6× 24 500
Takafumi Ogawa Japan 5 80 0.8× 21 0.4× 50 0.9× 17 0.4× 18 0.5× 14 294
Hanqing Zhao China 9 75 0.7× 30 0.5× 37 0.7× 10 0.2× 14 0.4× 18 245
Reda Ibrahem Egypt 12 53 0.5× 37 0.6× 68 1.2× 14 0.3× 11 0.3× 31 377

Countries citing papers authored by Fatemeh Tajik

Since Specialization
Citations

This map shows the geographic impact of Fatemeh Tajik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fatemeh Tajik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fatemeh Tajik more than expected).

Fields of papers citing papers by Fatemeh Tajik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fatemeh Tajik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fatemeh Tajik. The network helps show where Fatemeh Tajik may publish in the future.

Co-authorship network of co-authors of Fatemeh Tajik

This figure shows the co-authorship network connecting the top 25 collaborators of Fatemeh Tajik. A scholar is included among the top collaborators of Fatemeh Tajik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fatemeh Tajik. Fatemeh Tajik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Safari, Majid, Najma Farahani, Mina Alimohammadi, et al.. (2025). Metastasis and chemoresistance in breast cancer: Crucial function of ZEB1/2 proteins. Pathology - Research and Practice. 267. 155838–155838. 7 indexed citations
2.
Tajik, Fatemeh, et al.. (2025). Iterative Intraperitoneal Chemotherapy in Gastric Cancer Peritoneal Carcinomatosis. Cancers. 17(2). 289–289. 1 indexed citations
3.
Sedighim, Shaina, Fatemeh Tajik, Farshid Dayyani, et al.. (2025). Underutilization of Staging Laparoscopy Prior to Neoadjuvant Systemic Therapy in Gastric Cancer. Annals of Surgical Oncology. 33(2). 1343–1349.
4.
Tajik, Fatemeh, et al.. (2025). The association between tumor-stromal collagen features and the clinical outcomes of patients with breast cancer: a systematic review. Breast Cancer Research. 27(1). 69–69. 5 indexed citations
5.
Tajik, Fatemeh, et al.. (2024). Clinical significance of Talin-1 and HER-2 status in different types of gastric carcinoma. Biomarkers. 29(8). 539–556.
6.
Tajik, Fatemeh, et al.. (2024). Unraveling the potential of CD8, CD68, and VISTA as diagnostic and prognostic markers in patients with pancreatic ductal adenocarcinoma. Frontiers in Immunology. 15. 1283364–1283364. 7 indexed citations
7.
Sedighim, Shaina, et al.. (2024). Regional Therapy Approaches for Gastric Cancer with Limited Peritoneal Disease. Journal of Gastrointestinal Cancer. 55(2). 534–548. 3 indexed citations
8.
Razmi, Mahdieh, et al.. (2024). The Prognostic Importance of Ki-67 in Gastrointestinal Carcinomas: A Meta-analysis and Multi-omics Approach. Journal of Gastrointestinal Cancer. 55(2). 599–624. 1 indexed citations
9.
Tajik, Fatemeh, et al.. (2023). Clinical significance of CD166 and HER-2 in different types of gastric cancer. Clinical & Translational Oncology. 26(3). 664–681. 1 indexed citations
10.
Tajik, Fatemeh, et al.. (2023). The potential role of telemedicine in the infectious disease pandemic with an emphasis on COVID‐19: A narrative review. Health Science Reports. 6(1). e1024–e1024. 7 indexed citations
11.
Sedighim, Shaina, et al.. (2023). Adoption of cytoreductive surgery in the management of peritoneal malignancies—Global trends. Journal of Surgical Oncology. 128(6). 1021–1031. 2 indexed citations
12.
Gheytanchi, Elmira, Fatemeh Tajik, Mahdieh Razmi, et al.. (2023). Circulating exosomal microRNAs as potential prognostic biomarkers in gastrointestinal cancers: a systematic review and meta-analysis. Cancer Cell International. 23(1). 10–10. 5 indexed citations
13.
Tajik, Fatemeh, et al.. (2023). MicroRNA-372 acts as a double-edged sword in human cancers. Heliyon. 9(5). e15991–e15991. 11 indexed citations
14.
Tajik, Fatemeh, et al.. (2023). COVID-19 pandemic impact on screening and diagnosis of prostate cancer: a systematic review. BMJ Supportive & Palliative Care. 14(e2). e1594–e1603. 9 indexed citations
15.
Tajik, Fatemeh, et al.. (2022). Impact of COVID-19 pandemic on screening and diagnosis of patients with prostate cancer: a systematic review protocol. BMJ Open. 12(8). e063748–e063748. 5 indexed citations
16.
Raoofi, Samira, Fatemeh Pashazadeh Kan, Sima Rafiei, et al.. (2021). Anxiety during the COVID-19 pandemic in hospital staff: systematic review plus meta-analysis. BMJ Supportive & Palliative Care. 13(2). 127–135. 39 indexed citations
17.
Kan, Fatemeh Pashazadeh, Samira Raoofi, Sima Rafiei, et al.. (2021). A systematic review of the prevalence of anxiety among the general population during the COVID-19 pandemic. Journal of Affective Disorders. 293. 391–398. 98 indexed citations
18.
Darvishi‐Khezri, Hadi, et al.. (2021). Coadministration of silymarin with iron chelators in transfusion-dependent β-thalassemia patients: a systematic review and meta-analysis for effect on iron overload. Expert Review of Clinical Pharmacology. 14(11). 1445–1453. 1 indexed citations
19.
Malekan, Mohammad, et al.. (2020). Liver Function in Novel Coronavirus Disease (COVID-19): A Systematic Review and Meta-Analysis. medRxiv. 3 indexed citations
20.
Tajik, Fatemeh, et al.. (2018). Measurement of Visual Evoked Potentials in Patients with Spastic Cerebral Palsy. 2(1). 10–13. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026